Ocuphire Pharma, Inc.·4

Mar 25, 4:44 PM ET

SCHACHLE JOSEPH K 4

4 · Ocuphire Pharma, Inc. · Filed Mar 25, 2024

Insider Transaction Report

Form 4
Period: 2024-03-21
SCHACHLE JOSEPH K
Chief Operating Officer
Transactions
  • Purchase

    Common Stock

    2024-03-21$2.05/sh+2,000$4,1002,000 total

Documents

2 files